Hisky focuses on non-invasive disease diagnosis technologies and develops FibroTouch.
Hisky focuses on non-invasive disease diagnosis technologies and develops FibroTouch.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 17, 2021 | Series B | ¥100M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Zhonghui Investment | — | Series B |
Wuxi Hi-Tech Venture Capital | — | Series B |